OR WAIT null SECS
The evolution of therapeutic modalities drives the adoption of single-use technologies.
Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.
Given the criticality of fill/finish processes, it is clear that automation is the next technological step.
March 15, 2022
Why critical thinking must be applied before technology to ensure regulatory compliance.
March 14, 2022
Flow Eighteeen38 is receiving a €5 million (US$5.58 million) investment from its parent company, FairJourney Biologics.
March 10, 2022
Curia and the US government have entered into a cooperative agreement to expand fill/finish capability for injectable medicines.
UCB has announced it will build a new innovative gene therapy facility in Belgium.
March 09, 2022
Spectrum Chemical has further expanded its bioCERTIFIED product portfolio to support the growing global demand for new vaccines and therapeutics.
March 08, 2022
Amgen has announced the groundbreaking of its newest biomanufacturing facility in North Carolina.
Innovations address sustainable and patient-centric designs.
G-CON’s signature standardPOD cleanrooms will now be available in Europe.
Moderna has announced that it has entered a Memorandum of Understanding with the government of the Republic of Kenya to establish its first mRNA manufacturing facility in Africa.
What if we are underestimating China’s response to US/EU inshoring?